Severe Hypoglycaemia and Cognitive Impairment in Diabetes
BMJ 313:767-768, Deary,I.J., 1996
Diagnostic Test for the Prader-Willi Syndrome by SNRPN Expression in Blood
Lancet 348:1068-1069, Wevrick,R.&Francke,U., 1996
Prenatal Magnesium Sulfate Expos/Risk for CP or MR Among Very Low-Birth-Weight Child Aged 3-5 Yrs
JAMA 276:1805-1810, 18431996., Schendel,D.E.,et al, 1996
Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996
Cerebral Venous Thrombosis:Role of Activated Protein C Resistance and Factor V Gene Mutation
Stroke 27:1719-1720, Brey,R.L.&Coull,B.M., 1996
Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996
Neuropsychiatric Aspects of Progressive Supranuclear Palsy
Neurol 47:1184-1189, Litvan,I.,et al, 1996
Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996
Cognitive and Brain Magnetic Resonance Imaging Findings in Adrenomyeloneuropathy
Ann Neurol 40:675-678, Edwin,D.,et al, 1996
Unusual Clinical Presentations of Cortical-Basal Ganglionic Degeneration
Ann Neurol 40:893-900, Bergeron,C.,et al, 1996
Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
NEJM 335:1169-1175, 12221996., Durr,A.,et al, 1996
A Simplified Six-Item Checklist for Screening for Fragile X Syndrome in the Pediatric Population
J Pediatr 129:611-614, Giangreco,C.A.,et al, 1996
Influence of Apolipoprotein E Genotype on Cerebral Amyloid Angiopathy in the Elderly
Stroke 27:216-218, Itoh,Y.,et al, 1996
Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996
Differential Effect of Aspirin Vs Warfarin on Clinical Stroke Types in Pts with Atrial Fibrillation
Neurol 46:238-240, Miller,V.T.,et al, 1996
Progressive Ataxia, Focal Seizures, and Malabsorption Syndrome in a 41 Year Old Woman
JNNP 60:225-230, Mumford,C.J.,et al, 1996
Brief Report:Deficiency of a Dystrophin-Assoc Glycoprotein (Adhalin) in Pt with Muscular Dystrophy & Cardiomyopathy
NEJM 334:362-366, Fadic,R.,et al, 1996
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)
Ann Int Med 124:227-228, Bernstein,A.L.&Leventhal-Rochon,J.L., 1996
Clinicopath Conf
Tangier Disease, Case 16-1996, NEJM 334:1389-1394996., , 1996
Intelligence and the X Chromosome
Lancet 347:1814-1815, Turner,G., 1996
The Epilepsy of Trisomy 9p
Neurol 47:821-824, Stern,J.M., 1996
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E
NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996
Subcortical Heterotopia:A Distinct Clinicoradiologic Entity
AJNR 17:1315-1322, Barkovich,A.J., 1996
X-Linked Malformation of Neuronal Migration
Neurol 47:331-339, Dobyns,W.B.,et al, 1996
Iron Deficiency Anaemia and Febrile Convulsions:Case-Control Study in Children Under 2 Years
BMJ 313:343, Pisacane,A.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Startle Provoked Epileptic Seizures:Features in 19 Patients
JNNP 61:151-156, Manford,M.R.A.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
Diagnosis of McArdle's Disease by Molecular Genetic Analysis of Blood
Neurol 47:579-580, El-Schahawi,M.,et al, 1996
Congenital Muscular Dystrophy:Clinical & Pathologic Study of 50 Pts with Classical (Occidental) Merosin-Positive Form
Neurol 46:815-818, Kobayashi,O.,et al, 1996
Congenital Muscular Dystrophy Syndromes Distinguished by Alkaline and Acid Phosphatase, Merosin, & Dystrophin Staining
Neurol 46:810-814, Connolly,A.M.,et al, 1996
The Relation of Transient Hypothyroxinemia in Preterm Infants to Neurologic Development at Two Years of Age
NEJM 334:821-827, 8571996., Reuss,M.L.,et al, 1996
Ethylene Oxide Neurotoxicity:A Cluster of 12 Nurses with Peripheral and Central Nervous System Toxicity
Neurol 46:992-998, Brashear,A.,et al, 1996
Maternal Phenylketonuria:Magnetic Resonance Imaging of the Brain in Offspring
J Pediatr 128:770-775, Levy,H.L.,et al, 1996
Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996
Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996
Intellectual Impairment in Children Exposed to Polychlorinated Biphenyls in Utero
NEJM 335:783-789, Jacobson,J.L.,et al, 1996
Apolipoprotein E e4 is Associated with the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 27:1333-1337, Greenberg,S.M.,et al, 1996
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Ann Int Med 124:970-979, Fihn,S.D.,et al, 1996
Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke
Arch Int Med 154:637-642, Keli,S.O.,et al, 1996
Reduced Response to Activated Protein C is Associated with Increased Risk for Cerebrovascular Disease
Ann Int Med 125:265-269, van der Bom,J.G.,et al, 1996
Cerebral Venous Sinus Thrombosis Associated with Factor V Gene Mutation
JNNP 61:204-205, Kimber,T.,et al, 1996
Carotid Artery Thrombus Associated with Severe Iron-Deficiency Anemia and Thrombocytosis
Stroke 27:1002-1005, Akins,P.T.,et al, 1996
Apolipoprotein E and Cognitive Decline in Alzheimer's Disease
Neurol 47:317-320, Plassman,B.L.&Breitner,J.C.S., 1996
High Apolipoprotein E e4 Allele Frequency in Age-Related Memory Decline
Ann Neurol 39:548-551, Blesa,R.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
The Challenge of the Dementias
Lancet 347:1301-1307, Eastwood,R.,et al, 1996